A J Eerenberg-Belmer

719 total citations
16 papers, 591 citations indexed

About

A J Eerenberg-Belmer is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, A J Eerenberg-Belmer has authored 16 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 8 papers in Immunology and 7 papers in Genetics. Recurrent topics in A J Eerenberg-Belmer's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Complement system in diseases (5 papers) and Platelet Disorders and Treatments (3 papers). A J Eerenberg-Belmer is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Complement system in diseases (5 papers) and Platelet Disorders and Treatments (3 papers). A J Eerenberg-Belmer collaborates with scholars based in Netherlands, Switzerland and United States. A J Eerenberg-Belmer's co-authors include C. Erik Hack, C.E. Hack, A.J. Hannema, L. G. Thijs, John Wagstaff, T.A. Out, R.C. Aalberse, C C Huijbregts, Jan H. Nuijens and Gertjan Wolbink and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

A J Eerenberg-Belmer

16 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A J Eerenberg-Belmer Netherlands	12	312	203	175	88	68	16	591
Roger E Spitzer United States	15	445 1.4×	226 1.1×	187 1.1×	69 0.8×	42 0.6×	50	733
J. Jackson Ireland	14	133 0.4×	443 2.2×	258 1.5×	97 1.1×	168 2.5×	28	930
Shoichi Inaba Japan	16	269 0.9×	274 1.3×	101 0.6×	93 1.1×	30 0.4×	61	681
P H Schur United States	9	218 0.7×	91 0.4×	156 0.9×	37 0.4×	219 3.2×	12	490
U Nydegger Switzerland	15	276 0.9×	378 1.9×	61 0.3×	50 0.6×	59 0.9×	40	763
E Kelemen Hungary	14	351 1.1×	363 1.8×	230 1.3×	46 0.5×	31 0.5×	57	1.0k
Roula Farah Lebanon	11	231 0.7×	221 1.1×	86 0.5×	54 0.6×	20 0.3×	39	683
B. Fekete Hungary	14	248 0.8×	91 0.4×	241 1.4×	63 0.7×	267 3.9×	58	752
Rosa Ruchlemer Israel	14	139 0.4×	167 0.8×	360 2.1×	90 1.0×	57 0.8×	48	733
Francesco Puppo Italy	17	437 1.4×	183 0.9×	52 0.3×	100 1.1×	67 1.0×	45	983

Countries citing papers authored by A J Eerenberg-Belmer

Since Specialization

Citations

This map shows the geographic impact of A J Eerenberg-Belmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A J Eerenberg-Belmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A J Eerenberg-Belmer more than expected).

Fields of papers citing papers by A J Eerenberg-Belmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A J Eerenberg-Belmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A J Eerenberg-Belmer. The network helps show where A J Eerenberg-Belmer may publish in the future.

Co-authorship network of co-authors of A J Eerenberg-Belmer

This figure shows the co-authorship network connecting the top 25 collaborators of A J Eerenberg-Belmer. A scholar is included among the top collaborators of A J Eerenberg-Belmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A J Eerenberg-Belmer. A J Eerenberg-Belmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zeerleder, Sacha, et al.. (2005). Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction. Clinical Immunology. 116(2). 158–165. 47 indexed citations

Zeerleder, Sacha, Christoph Caliezi, Gerard van Mierlo, et al.. (2003). Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis. Clinical and Vaccine Immunology. 10(4). 529–535. 57 indexed citations

Wagstaff, John, Johanna W. Baars, Gertjan Wolbink, et al.. (1995). Renal cell carcinoma and interleukin-2: A review. European Journal of Cancer. 31(3). 401–408. 6 indexed citations

Baars, Johanna W., Gertjan Wolbink, M. Hart, et al.. (1994). The release of interleukin-8 during intravenous bolus treatment with interleukin-2. Annals of Oncology. 5(10). 929–934. 11 indexed citations

Baars, Johanna W., John Wagstaff, C.E. Hack, et al.. (1992). Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2). Annals of Oncology. 3(3). 243–244. 8 indexed citations

Baars, Johanna W., C. Erik Hack, John Wagstaff, et al.. (1992). The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant Interleukin-2. British Journal of Cancer. 65(1). 96–101. 39 indexed citations

Baars, Johanna W., Jan Paul de Boer, John Wagstaff, et al.. (1992). Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia. British Journal of Haematology. 82(2). 295–301. 47 indexed citations

Thijs, L. G., et al.. (1990). Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects.. The Journal of Immunology. 144(6). 2419–2424. 67 indexed citations

Nuijens, Jan H., C C Huijbregts, A J Eerenberg-Belmer, et al.. (1989). Activation of the Contact System of Coagulation by a Monoclonal Antibody Directed Against a Neodeterminant in the Heavy Chain Region of Human Coagulation Factor XII (Hageman Factor). Journal of Biological Chemistry. 264(22). 12941–12949. 27 indexed citations

10.

Wagstaff, John, Jan B. Vermorken, Gilberto Schwartsmann, et al.. (1989). A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2. Cancer Treatment Reviews. 16. 105–109. 7 indexed citations

11.

Nuijens, Jan H., A J Eerenberg-Belmer, C C Huijbregts, et al.. (1989). Proteolytic inactivation of plasma C1- inhibitor in sepsis.. Journal of Clinical Investigation. 84(2). 443–450. 113 indexed citations

12.

Hack, C. Erik, et al.. (1984). Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis. Arthritis & Rheumatism. 27(1). 40–48. 25 indexed citations

13.

Hannema, A.J., et al.. (1984). SLE like syndrome and functional deficiency of C1q in members of a large family.. PubMed. 55(1). 106–14. 39 indexed citations

14.

Hack, C.E., A.J. Hannema, A J Eerenberg-Belmer, T.A. Out, & R.C. Aalberse. (1982). A C1-inhibitor-complex assay (INCA): A method to detect c1 activation in vitro and in vivo. Molecular Immunology. 19(11). 1373–1373. 2 indexed citations

15.

Hack, C.E., A.J. Hannema, A J Eerenberg-Belmer, T.A. Out, & R.C. Aalberse. (1981). A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.. The Journal of Immunology. 127(4). 1450–1453. 65 indexed citations

16.

Hack, C.E., A J Eerenberg-Belmer, A.J. Hannema, T.A. Out, & R.C. Aalberse. (1981). Polyethylene glycol enhances the binding of C1q to circulating immune complexes. Journal of Immunological Methods. 44(2). 211–221. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact